[144] MAXIMUS, INC. SEC Filing

Rhea-AI Filing Summary

MAXIMUS, Inc. (MMS) filed a Form 144 notifying the proposed sale of 1,610 common shares held at Fidelity Brokerage Services with an aggregate market value of $146,284.60. The shares represent vested restricted stock acquired and paid as compensation on 09/30/2025. The filing lists approximately 56,349,629 shares outstanding for the issuer and an approximate sale date of 10/01/2025 on the NYSE. No securities were reported sold by the filer in the past three months. The notice includes the filer’s representation that they do not possess undisclosed material adverse information about the issuer.

Positive

• Disclosure compliance: The filer submitted a Form 144 documenting the proposed sale, supporting regulatory transparency.
• Small relative size: 1,610 shares equal approximately 0.0029% of the reported 56,349,629 outstanding shares, indicating limited market impact.
• Source of shares disclosed: Shares were acquired via restricted stock vesting and classified as compensation, clarifying the transaction origin.

Negative

• None.

Insights

Securities Analyst

TL;DR: Small, routine insider sale of recently vested restricted stock; unlikely to move the market given its negligible size versus outstanding shares.

The filing shows a proposed sale of 1,610 common shares valued at $146,284.60, representing approximately 0.0029% of the issuer's reported outstanding shares (1,610 of 56,349,629). The shares were acquired via restricted stock vesting and classified as compensation on 09/30/2025, with an intended sale date of 10/01/2025 through Fidelity on the NYSE. This appears to be a standard compliance disclosure under Rule 144 rather than a sign of material liquidity or change in ownership. Absence of any sales in the prior three months reduces the likelihood of an ongoing selling program.

Corporate Governance Expert

TL;DR: Filing documents a routine disposal of vested compensation; form and disclosures align with insider reporting expectations.

The notice fulfils Rule 144 disclosure for an insider disposing of restricted stock received as compensation. Key governance points: the filer certifies no undisclosed material adverse information, the transaction is routed through a broker (Fidelity), and no aggregation of recent sales is reported. From a governance perspective, this is a routine transparency action and does not indicate policy or control changes at the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1610	146284.60	56349629	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2025	Restricted Stock Vesting	Issuer			1610	09/30/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does MAXIMUS (MMS) report in this Form 144 filing?

The filing notifies a proposed sale of 1,610 common shares held at Fidelity with aggregate market value $146,284.60, acquired via restricted stock vesting on 09/30/2025.

When is the approximate sale date for the shares listed in the Form 144?

The filing indicates an approximate sale date of 10/01/2025 on the NYSE through Fidelity Brokerage Services.

How large is the proposed sale relative to MAXIMUS's outstanding shares?

The proposed sale of 1,610 shares represents about 0.0029% of the reported 56,349,629 shares outstanding, based on numbers in the filing.

Were any shares sold by the filer in the past three months according to the filing?

No. The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

What was the nature of acquisition and payment for the securities?

The securities were acquired on 09/30/2025 through Restricted Stock Vesting from the issuer, and the payment/nature is listed as Compensation.